SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-065768
Filing Date
2017-11-03
Accepted
2017-11-02 18:32:26
Documents
3
Period of Report
2017-11-02
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-25145_18k.htm 8-K 25148
2 EX-99.1 a17-25145_1ex99d1.htm EX-99.1 11930
3 GRAPHIC g251451mmi001.jpg GRAPHIC 2701
  Complete submission text file 0001104659-17-065768.txt   42049
Mailing Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046
Business Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 443-545-1819
OSIRIS THERAPEUTICS, INC. (Filer) CIK: 0001360886 (see all company filings)

IRS No.: 710881115 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32966 | Film No.: 171174071
SIC: 2836 Biological Products, (No Diagnostic Substances)